Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug-Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed)

Archived opportunity record

Validating Human Stem Cell Cardiomyocyte Tech… is closed (last close April 4, 2019). The parent program page for CFDA 93.103 is the reliable place to catch re-announcements. Food and Drug Administration still indexes 481 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Market-open applicant set · includes for-profit door

The eligibility set for Validating Human Stem Cell Cardiomyocyte Tech… includes a for-profit door among 11 printed types (State governments; City or township governments; Independent school districts; Public / state-controlled institutions of higher education; +7 more). Competitive traffic can include commercial applicants alongside other listed classes. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Agriculture · Consumer Protection · Food and Nutrition (AG;CP;FN). Inside Food and Drug Administration's indexed book this exact eligibility-code string is unique to this listing.

Code 00

State governments

Code 02

City or township governments

Code 05

Independent school districts

Code 06

Public / state-controlled institutions of higher education

Code 07

Federally recognized tribal governments

Code 11

Native American tribal organizations (other than Federally recognized tribal governments)

Code 12

Nonprofits with 501(c)(3) status (other than IHEs)

Code 13

Nonprofits without 501(c)(3) status (other than IHEs)

Code 20

Private institutions of higher education

Code 23

Small businesses

Code 25

Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.